Two Sigma Securities, LLC Protalix Bio Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.1 - $1.32 $36,292 - $43,550	-32,993 Reduced 38.67%	52,320 $61,000
Q1 2024 May 15, 2024	BUY	$1.22 - $1.82 $49,823 - $74,326	40,839 Added 91.83%	85,313 $107,000
Q4 2023 Feb 14, 2024	BUY	$1.34 - $1.85 $59,595 - $82,276	44,474 New	44,474 $79,000
Q2 2023 Aug 14, 2023	SELL	$2.0 - $3.36 $10,968 - $18,426	-5,484 Reduced 26.42%	15,276 $30,000
Q1 2023 May 15, 2023	BUY	$1.37 - $2.16 $28,441 - $44,841	20,760 New	20,760 $43,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $87.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.